Fatih Arslan - Concepedia

Author

Fatih Arslan

Also Known As

Bongiorno, Andrea, F Arslan, F. Arslan, F. Necati Arslan, Fatih ARSLAN, Fatih Arslan, Fatih Arslan (682413), Peter R. Stella

105

Publications

9.8K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Netherlands Heart Institute Institute of Medical Biology Agency for Science, Technology and Research Leiden University Medical Center

About

Fatih Arslan is an author at University Medical Center Utrecht specializing in medicine, cell biology, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	5.5K
2	Cell Biology	9	9	5.1K
3	Natural Sciences	4	4	644
4	Biomedical Engineering	3	3	1.7K
5	Biochemistry	2	2	117

Fatih Arslan

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury Ruenn Chai Lai, Fatih Arslan, May May Lee, Stem Cell Research Cell PhysiologyProtein SecretionImmunologyExtracellular MicrovesiclesExosome Biology	2010	2.2K
Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury Fatih Arslan, Ruenn Chai Lai, Mirjam B. Smeets, Stem Cell Research Regenerative MedicineMedicineAdult Stem CellCardiac Progenitor CellsAtp Levels	2013	1.1K
Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium Leo Timmers, Sai Kiang Lim, Fatih Arslan, Stem Cell Research Regenerative MedicineTissue EngineeringMedicineAdult Stem CellMyocardial Infarct Size	2008	613
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome Ruenn Chai Lai, Soon Sim Tan, Bao Ju Teh, International Journal of Proteomics Msc Exosome ProteomeImmunologyProteasomeMolecular BiologyExtracellular Microvesicles	2012	490
Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction Leo Timmers, Sai Kiang Lim, Imo E. Hoefer, Stem Cell Research Regenerative MedicineCardiac FunctionMedicineAdult Stem CellStem Cell Research	2011	423
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs Tian Sheng Chen, Fatih Arslan, Yijun Yin, Journal of Translational Medicine	2011	393
Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody Fatih Arslan, Mirjam B. Smeets, Luke O'neill, Circulation	2009	344
Right Ventricular Dysfunction in Left-Sided Heart Failure with Preserved Versus Reduced Ejection Fraction Lena Bosch, Carolyn S.P. Lam, Lingli Gong, European Journal of Heart Failure	2017	341
Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo Marish I.F.J. Oerlemans, Jia Liu, Fatih Arslan, Basic Research in Cardiology Cardiovascular DiseaseMedicineVascular BiologyReperfusion InjuryMyocardial Ischemia–reperfusion	2012	318
The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction Gerardus P. J. van Hout, Lena Bosch, Guilielmus H.J.M. Ellenbroek, European Heart Journal	2016	317

Page 1